Tolmar
Tolmar is a privately held Colorado company that makes Eligard, the subcutaneous depot of the hormone therapy leuprolide used to suppress testosterone in advanced prostate cancer.
Overview
Tolmar, based in Fort Collins, Colorado, develops and manufactures long-acting injectables using its Atrigel polymer depot technology. Its main product is Eligard (leuprolide acetate for injectable suspension), a gonadotropin-releasing hormone agonist given every one to six months for palliative treatment of advanced prostate cancer, sold in the United States by Tolmar and abroad through partners; it runs phase 3 trials of new formulations and dosing intervals. It appears on OnCo as a lead sponsor of phase 3 cancer trials on ClinicalTrials.gov.
Scorecard
All companies- approved products +6
- targets +2
- modalities +2
- regions +6
- registry trials +8
Similar pages
not linked directly; found by shared links- CompanyBavarian Nordic
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyFutureChem
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyHinova Pharmaceuticals
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanySpectraCure
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanySOTIO Biotech
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyVeru
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyAB Science
Shares Prostate cancer and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Prostate cancer and the tag ctgov-sponsor.